Insmed Incorporated ( INSM) - Key Metrics
INSM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.24 | -$1.54 | -$1.16 | -$1.38 |
| 2025Q3 | $0.67 | -$1.75 | -$1.04 | -$1.05 |
| 2025Q2 | $0.57 | -$1.70 | -$1.09 | -$1.10 |
| 2025Q1 | $0.51 | -$1.42 | -$1.45 | -$1.50 |
INSM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -28.30 |
| 2025Q3 | ? | -20.60 |
| 2025Q2 | ? | -14.81 |
| 2025Q1 | ? | -13.44 |
INSM
Price: $98.24
52 week price:
Earnings Per Share: -5.77 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -42.9 millionMarket Capitalization: 20.4 billion